Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole

PHASE3RecruitingINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2029

Conditions

Chronic Pulmonary Aspergillosis

Interventions

DRUG

inhaled Ambisome®

inhaled liposomal amphotericin B = inhaled LAmB

DRUG

inhaled placebo

inhaled isotonic saline

DRUG

Itraconazole

Itraconazole tablet

Trial Locations (1)

RECRUITING

CHU Poitiers, Poitiers

All Listed Sponsors

lead

Poitiers University Hospital

OTHER